YBX1 and breast carcinoma: Specifically, in breast cancer cells, tRF-2s from tRNAGlu, tRNAAsp, tRNAGly and tRNATyr have been shown to suppress metastasis through binding to YBX1, thus inhibiting its engagement with oncogenic mRNAs (Zeng et al., 2020).